Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Diagnostic Value of Prolactin Adjustment in Bilateral Inferior Petrosal Sinus Sampling for Differentiating Cushing’S Disease From the Ectopic Acth Syndrome: A Systematic Review and Meta-Analysis Publisher Pubmed



Valizadeh M1 ; Ahmadi AR2 ; Hussein DR3 ; Emdadi F3 ; Hosseinpanah F1 ; Grossman A4, 5, 6 ; Abiri B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, United Kingdom
  5. 5. ENETS Centre of Excellence, Royal Free Hospital, London, NW3 2QG, United Kingdom
  6. 6. Green Templeton College, University of Oxford, Oxford, United Kingdom

Source: Pituitary Published:2025


Abstract

Background: Adrenocorticotropin (ACTH)-dependent Cushing’s syndrome can arise from a pituitary tumour (Cushing’s disease) or an ectopic ACTH-secreting tumour, making precise differentiation essential for effective treatment. Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for this differentiation, but false-negative results can limit its accuracy. Adding prolactin (PRL) measurement to BIPSS has been proposed to improve diagnostic precision. This meta-analysis evaluates how correction for prolactin levels (‘prolactin adjustment’) affects the diagnostic value of BIPSS in distinguishing Cushing’s disease from ectopic ACTH syndrome. Methods: A systematic literature search was conducted in PubMed, Scopus, EMBASE, Web of Science, and Google Scholar up to July 2024. Studies were included if they provided data on BIPSS with and without PRL adjustment for ACTH-dependent Cushing’s syndrome. Data extraction and quality assessment were performed, and diagnostic accuracy metrics were analysed using bivariate generalised linear mixed modelling. Results: A total of 10 studies with 310 participants were included. The pooled sensitivity and specificity of BIPSS with PRL adjustment were 0.96 (95% CI: 0.93–0.98) and 0.68 (95% CI: 0.52–0.81), respectively. The diagnostic odds ratio (DOR) was 48.0 (95% CI: 19.0–123.0), with a positive likelihood ratio (LR) of 3.00 (95% CI: 1.9–4.7) and a negative LR of 0.06 (95% CI: 0.03–0.12). The area under the summary receiver operating characteristic (SROC) curve was 0.95 (95% CI: 0.93–0.97). For BIPSS without PRL adjustment, the pooled sensitivity was 0.90 (95% CI: 0.86–0.93) and specificity was 0.74 (95% CI: 0.59–0.85), with a DOR of 27.0 (95% CI: 13.0–59.0). The SROC curve area was 0.92 (95% CI: 0.89–0.94). Prolactin adjustment improved sensitivity (P < 0.01) without a significant change in specificity (P = 0.13). Conclusions: Prolactin adjustment in BIPSS slightly improves sensitivity for diagnosing Cushing’s disease but does not enhance specificity for ectopic ACTH syndrome. This highlights the value of PRL measurement in improving diagnostic accuracy and reducing false negatives, while BIPSS remains crucial for ruling out EAS in clinical practice. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.